Specificity, or the true negative rate, measures the proportion of actual negatives that are correctly identified. This metric indicates how effectively a test can identify individuals who do not have the disease. High specificity is crucial when the cost of a false positive is high, such as in conditions where unnecessary treatment may cause harm or lead to significant healthcare costs.
